Cargando…
Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes
Obesity and diabetes are often associated with lipotoxic conditions in multiple tissues. The insulin-producing β cells are susceptible to elevated lipid levels and the ensuing lipotoxicity. The preservation of β cell mass and function is one of the main goals of diabetes management under these metab...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391718/ https://www.ncbi.nlm.nih.gov/pubmed/30834357 http://dx.doi.org/10.1210/js.2018-00372 |
_version_ | 1783398353491460096 |
---|---|
author | Ye, Risheng Onodera, Toshiharu Scherer, Philipp E |
author_facet | Ye, Risheng Onodera, Toshiharu Scherer, Philipp E |
author_sort | Ye, Risheng |
collection | PubMed |
description | Obesity and diabetes are often associated with lipotoxic conditions in multiple tissues. The insulin-producing β cells are susceptible to elevated lipid levels and the ensuing lipotoxicity. The preservation of β cell mass and function is one of the main goals of diabetes management under these metabolically stressful conditions. However, the adverse effects from the adaptive signaling pathways that β cells use to counteract lipotoxic stress have secondary negative effects in their own right. Antilipotoxic signaling cascades in β cells can contribute to their eventual failure. Such dual roles are seen for many other biological adaptive processes as well. |
format | Online Article Text |
id | pubmed-6391718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-63917182019-03-04 Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes Ye, Risheng Onodera, Toshiharu Scherer, Philipp E J Endocr Soc Mini-Review Obesity and diabetes are often associated with lipotoxic conditions in multiple tissues. The insulin-producing β cells are susceptible to elevated lipid levels and the ensuing lipotoxicity. The preservation of β cell mass and function is one of the main goals of diabetes management under these metabolically stressful conditions. However, the adverse effects from the adaptive signaling pathways that β cells use to counteract lipotoxic stress have secondary negative effects in their own right. Antilipotoxic signaling cascades in β cells can contribute to their eventual failure. Such dual roles are seen for many other biological adaptive processes as well. Endocrine Society 2019-02-04 /pmc/articles/PMC6391718/ /pubmed/30834357 http://dx.doi.org/10.1210/js.2018-00372 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Mini-Review Ye, Risheng Onodera, Toshiharu Scherer, Philipp E Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes |
title | Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes |
title_full | Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes |
title_fullStr | Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes |
title_full_unstemmed | Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes |
title_short | Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes |
title_sort | lipotoxicity and β cell maintenance in obesity and type 2 diabetes |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391718/ https://www.ncbi.nlm.nih.gov/pubmed/30834357 http://dx.doi.org/10.1210/js.2018-00372 |
work_keys_str_mv | AT yerisheng lipotoxicityandbcellmaintenanceinobesityandtype2diabetes AT onoderatoshiharu lipotoxicityandbcellmaintenanceinobesityandtype2diabetes AT schererphilippe lipotoxicityandbcellmaintenanceinobesityandtype2diabetes |